COVID-19: Another Reason for Anticoagulation in Patients with Atrial Fibrillation
Overview
Authors
Affiliations
COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation.
Yang L, Tang S, Guo J, Gabriel N, Gellad W, Essien U Am J Cardiovasc Drugs. 2024; 24(5):693-702.
PMID: 39136872 DOI: 10.1007/s40256-024-00671-3.
Yang L, Tang S, He M, Guo J, Gabriel N, Swabe G BMC Cardiovasc Disord. 2023; 23(1):604.
PMID: 38066445 PMC: 10704685. DOI: 10.1186/s12872-023-03614-z.
From post-COVID-19-associated myocarditis to hemopericardium: a dangerous domino effect.
Bellanti F, Amato R, Centola A, Ercolano V, Barbera L, Tesse A J Geriatr Cardiol. 2023; 20(5):391-396.
PMID: 37397864 PMC: 10308175. DOI: 10.26599/1671-5411.2023.05.008.
Kanuri S, Sirrkay P, Ulucay A Egypt Heart J. 2023; 75(1):36.
PMID: 37120772 PMC: 10149046. DOI: 10.1186/s43044-023-00359-0.
COVID-19 and atrial fibrillation: Intercepting lines.
Donniacuo M, De Angelis A, Rafaniello C, Cianflone E, Paolisso P, Torella D Front Cardiovasc Med. 2023; 10:1093053.
PMID: 36755799 PMC: 9899905. DOI: 10.3389/fcvm.2023.1093053.